abstract |
(57) [Summary]nThe present invention provides non-useful treatments for conditions mediated by angiogenesis such as cancer, hemangiomas, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity. It is an irreversible inhibitor of peptidic type 2 methionine aminopeptidase. |